Agenus | AGEN - Trade Debtors


Agenus reported $22.44M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agenus USD 22.44M 1.14M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Celldex Therapeutics USD 2.02M 1.92M Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
J&J USD 17.61B 235M Sep/2025
Jiangsu Hengrui CNY 5.94B 326.03M Dec/2025
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
MacroGenics USD 13.37M 55.86M Dec/2025
Merck EUR 4.44B 293M Dec/2025
Merck USD 12.12B 596M Sep/2025
Novartis USD 12.29B 3.3B Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Veracyte USD 44.66M 3.17M Dec/2025